Bristol-Myers forecasts 2016 profit above Wall Street estimates

Jan 27 (Reuters) - Bristol-Myers Squibb Co reported better-than-expected quarterly results, helped by strong sales of its cancer treatments and its Eliquis pill to prevent blood clots, and predicted 2016 earnings slightly above Wall Street forecasts.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.